Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

新闻与事件

新闻活动

Court of Appeal confirms strike-out of claim for loss under “unlawful means” tort

日期: 19 September 2019

EmailTwitterLinkedInXingWeChat

 

In the Secretary of State for Health & Anor v Servier Laboratories Ltd & Ors [2019] EWCA Civ 1160, the latest chapter of litigation involving Servier’s branded perindopril drug, Coversyl, the Court of Appeal has unanimously dismissed an appeal against a decision of Mr Justice Roth to strike out the NHS’s claim for damages for loss caused by unlawful means.

 

The alleged loss was the higher price paid by the NHS for perindopril. The unlawful means were alleged misrepresentations made by Servier to the European Patent Office (EPO) and the English Courts in the course of obtaining its patent for the pharmaceutical drug and during the course of obtaining an interlocutory injunction to enforce the patent pending trial, which caused a delayed introduction into the UK of a cheaper generic version of the drug.

 

The Court of Appeal confirmed that the tort of causing loss by unlawful means required (among other things) that the alleged unlawful means had to affect the freedom of the third party to deal with the claimant. In this case, the “third party” were the EPO and the English court and, as there was no question of interference with their “freedom to deal” with the NHS (or indeed with anyone else), the claim fell outside the scope of that tort.

 

This judgment confirms that interference by the defendant with the liberty of a third party to deal with the claimant is an essential ingredient of the tort of causing loss by unlawful means. The decision provides a comprehensive analysis of the authorities related to the unlawful means tort; in particular OBG, which the court acknowledged as a binding precedent.

 

The next chapter in this litigation will be the mitigation trial, now listed to be heard in October 2019 and expected to last 22 days with numerous expert witnesses being called.

 

Our full article on this case will appear in the Journal of Intellectual Property Law & Practice.

 

Contact our Life Sciences team for more information.

 

C
本网站使用cookies。

其中一些cookies是必要的,而另一些cookies则通过分析网站的使用方式来帮助我们改善您的用户体验。有关我们使用的cookies的更多详细信息,请查看我们的隐私政策

必要的Cookies

必要的cookies可实现网站核心功能。 没有这些cookies,网站将无法正常运行。这些cookies只能通过更改浏览器选项来禁用。

分析性Cookies

分析性cookies通过收集和报告使用信息帮助我们改进网站。

x